Research Methodology – Oncology Drugs Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Oncology Drugs Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Oncology Drugs Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Number of cancer patients worldwide and in specific regions
- Type and stage of cancer the drugs are targeted against
- Number and type of oncology drugs available in the market
- Pricing of oncology drugs
- Government policies and support in terms of healthcare funding
- Study of the competitors in the market
- Technological advancements in cancer treatment
- Research and development activities in the oncology drug sector
- Health insurance coverage and out-of-pocket patient expenditure
Key Market Indicators
- Growth rate of cancer incidences globally
- Amount of funding available for cancer treatment and research
- Successful market launch of new drugs
- Regulations related to drug approval and pricing
- Patent expiry of popular oncology drugs
- Technological advancements and acceptance rate
Growth Trends
- Increasing demand for personalized medicine in cancer treatment
- Growing research in immuno-oncology and targeted therapy
- Increasing trend of partnerships and collaborations among pharmaceutical companies
- Increasing cancer incidences due to an aging population
- Trends in healthcare policies towards cancer treatment and funding
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Oncology Drugs Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Oncology Drugs Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
